A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine Against Shigella Sonnei Administered Intramuscularly to Adults From a Shigellosis-Endemic Country

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2017.01884

Related search